Finance

Lists
Why is ABEO up 5.68%?
Dive Deeper
ABEO:NASDAQ
Abeona Therapeutics Inc
$2.42
+5.68%
(+0.13) 1D
$2.35
-2.89% (-0.070)
After hours
Closed: Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ABEO...
Open
$2.32
High
$2.44
Low
$2.09
Mkt. cap
138.30M
Avg. vol.
1.80M
Volume
3.18M
52-wk high
$7.65
52-wk low
$2.09
EPS
-$1.11
Beta
1.50
Shares outstanding
57.15M
No. of employees
226
Open
$2.32
High
$2.44
Low
$2.09
Mkt. cap
138.30M
Avg. vol.
1.80M
Volume
3.18M
52-wk high
$7.65
52-wk low
$2.09
EPS
-$1.11
Beta
1.50
Shares outstanding
57.15M
No. of employees
226
News stories
From web sources and news partners
About Abeona Therapeutics Inc
CEO-
Employees226
Founded1974
HeadquartersCleveland, Ohio, United States
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 4 analysts giving stock ratings to ABEO in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ABEO in the last 3 months.
Highest
Current $2.42
$30.00 (+1,139.67%)
Average
$19.13 (+690.50%)
Lowest
$7.50 (+209.92%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$18.00
+643.8%
11/13/2026
Boobalan Pachaiyappan
Roth MKM
Buy
Reiterated
$7.50
+209.9%
11/10/2026
Unknown Analyst
Oppenheimer
Buy
Reiterated
$21.00
+767.8%
11/10/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
$30.00
+1,139.7%
09/17/2026
Unknown Analyst
Jefferies
Buy
Maintained
$17.00
+602.5%
05/14/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
$20.00
+726.4%
05/13/2026
Stephen Willey
Stifel Nicolaus
Buy
Maintained
$17.00
+602.5%
03/18/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
5.42M
8.72M
11.38M
13.49M
Cost of goods sold
9.55M
12.25M
9.20M
9.38M
Cost of revenue
9.55M
12.25M
9.20M
9.38M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18.78M
19.50M
15.84M
17.11M
Operating expense
18.78M
19.50M
15.84M
17.11M
Total operating expenses
28.33M
31.75M
25.03M
26.49M
Operating income
-22.91M
-23.03M
-13.65M
-13.00M
Other non operating income
1.57M
5.44M
-7.20M
6.50M
EBT including unusual items
-20.68M
-17.07M
-20.19M
-4.79M
EBT excluding unusual items
-20.68M
-17.07M
-20.19M
-4.79M
Income tax expense
-215.00K
2.00K
-
18.00K
Effective tax rate
1.04%
-0.01%
-
-0.38%
Other operating expenses
-
-
-
-
Net income
-20.46M
-17.08M
-20.19M
-4.81M
Net profit margin
-377.49%
-195.81%
-177.43%
-35.64%
Earnings per share
-0.37
-0.30
-0.35
-0.08
Interest and investment income
1.55M
1.35M
1.36M
2.26M
Interest expense
-884.00K
-830.00K
-696.00K
-557.00K
Net interest expenses
663.00K
524.00K
659.00K
1.71M
Depreciation and amortization charges
-
-
-
-
EBITDA
-22.05M
-22.34M
-12.99M
-12.30M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps